Literature DB >> 11986266

YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis.

Christian Østergaard1, Julia S Johansen, Thomas Benfield, Paul A Price, Jens D Lundgren.   

Abstract

YKL-40, a member of the family 18 glycosyl hydrolases, is secreted by activated neutrophils and macrophages. It is a growth factor for connective tissue cells and a potent migration factor for endothelial cells and may function in inflammation and tissue remodeling. YKL-40 was determined in 134 cerebrospinal fluid (CSF) samples taken on admission from patients suspected of having meningitis (48 with purulent meningitis, 49 with lymphocytic meningitis, 5 with encephalitis, and 32 without evidence of meningitis). YKL-40 levels in CSF were significantly higher in patients with purulent meningitis (median, 663 microg/liter [range, 20 to 8,960]) and encephalitis (5,430 microg/liter [620 to 11,600]) than in patients with lymphocytic meningitis (137 microg/liter [41 to 1,865]) or patients without meningitis (167 microg/liter [24 to 630]) (Kruskal-Wallis and Dunn multiple comparison tests, P < 0.001). CSF YKL-40 levels were also determined for 26 patients with purulent meningitis having a repuncture, and patients who died (n = 5) had significantly higher YKL-40 levels than patients who survived (n = 21) (2,100 microg/liter [1,160 to 7,050] versus 885 microg/liter [192 to 15,400], respectively; Mann-Whitney test, P = 0.018). YKL-40 was most likely locally produced, since patients with infections of the central nervous system had CSF YKL-40 levels that were at least 10-fold higher than the corresponding levels in serum (2,033 microg/liter [470 to 11,600] versus 80 microg/liter [19 to 195]). The CSF neopterin level was the biochemical parameter in CSF and blood that correlated best with CSF YKL-40 levels, indicating that YKL-40 may be produced by activated macrophages within the central nervous system. In conclusion, high levels of YKL-40 in CSF are found in patients with purulent meningitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986266      PMCID: PMC119997          DOI: 10.1128/cdli.9.3.598-604.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  32 in total

1.  Identification of a novel eosinophil chemotactic cytokine (ECF-L) as a chitinase family protein.

Authors:  M Owhashi; H Arita; N Hayai
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

2.  Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?

Authors:  J S Johansen; S Møller; P A Price; F Bendtsen; J Junge; C Garbarsch; J H Henriksen
Journal:  Scand J Gastroenterol       Date:  1997-06       Impact factor: 2.423

3.  YKL-40 in giant cells and macrophages from patients with giant cell arteritis.

Authors:  J S Johansen; B Baslund; C Garbarsch; M Hansen; M Stoltenberg; I Lorenzen; P A Price
Journal:  Arthritis Rheum       Date:  1999-12

4.  The distribution of YKL-40 in osteoarthritic and normal human articular cartilage.

Authors:  B Volck; K Ostergaard; J S Johansen; C Garbarsch; P A Price
Journal:  Scand J Rheumatol       Date:  1999       Impact factor: 3.641

5.  Chondrex: new marker of joint disease.

Authors:  S Harvey; M Weisman; J O'Dell; T Scott; M Krusemeier; J Visor; C Swindlehurst
Journal:  Clin Chem       Date:  1998-03       Impact factor: 8.327

6.  Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation.

Authors:  M Rehli; S W Krause; R Andreesen
Journal:  Genomics       Date:  1997-07-15       Impact factor: 5.736

7.  Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.

Authors:  R G Boot; T A van Achterberg; B E van Aken; G H Renkema; M J Jacobs; J M Aerts; C J de Vries
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

8.  Pretreatment with granulocyte colony-stimulating factor attenuates the inflammatory response but not the bacterial load in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits.

Authors:  C Ostergaard; T Benfield; B Gesser; A Kharazmi; N Frimodt-Møller; F Espersen; J D Lundgren
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

9.  A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid.

Authors:  J S Johansen; H S Jensen; P A Price
Journal:  Br J Rheumatol       Date:  1993-11

10.  YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils.

Authors:  B Volck; P A Price; J S Johansen; O Sørensen; T L Benfield; H J Nielsen; J Calafat; N Borregaard
Journal:  Proc Assoc Am Physicians       Date:  1998 Jul-Aug
View more
  42 in total

Review 1.  New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma.

Authors:  Daniel Elieh Ali Komi; Tohid Kazemi; Anton Pieter Bussink
Journal:  Curr Allergy Asthma Rep       Date:  2016-08       Impact factor: 4.806

2.  YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease.

Authors:  Rebecca Craig-Schapiro; Richard J Perrin; Catherine M Roe; Chengjie Xiong; Deborah Carter; Nigel J Cairns; Mark A Mintun; Elaine R Peskind; Ge Li; Douglas R Galasko; Christopher M Clark; Joseph F Quinn; Gina D'Angelo; James P Malone; R Reid Townsend; John C Morris; Anne M Fagan; David M Holtzman
Journal:  Biol Psychiatry       Date:  2010-11-15       Impact factor: 13.382

3.  Chitinase-like proteins in lung injury, repair, and metastasis.

Authors:  Chun Geun Lee; Charles S Dela Cruz; Bing Ma; Farida Ahangari; Yang Zhou; Ruth Halaban; Mario Sznol; Jack A Elias
Journal:  Proc Am Thorac Soc       Date:  2012-05

Review 4.  Progress update: fluid and imaging biomarkers in Alzheimer's disease.

Authors:  Courtney L Sutphen; Anne M Fagan; David M Holtzman
Journal:  Biol Psychiatry       Date:  2013-09-05       Impact factor: 13.382

Review 5.  Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells.

Authors:  Katrin Eurich; Mayuko Segawa; Satoko Toei-Shimizu; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

6.  Human chitinases and chitinase-like proteins as indicators for inflammation and cancer.

Authors:  Julia Kzhyshkowska; Alexei Gratchev; Sergij Goerdt
Journal:  Biomark Insights       Date:  2007-05-03

7.  In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases.

Authors:  Dafna Bonneh-Barkay; Guoji Wang; Adam Starkey; Ronald L Hamilton; Clayton A Wiley
Journal:  J Neuroinflammation       Date:  2010-06-11       Impact factor: 8.322

8.  Role of breast regression protein-39/YKL-40 in asthma and allergic responses.

Authors:  Chun Geun Lee; Jack A Elias
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764

9.  Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection.

Authors:  Christian Østergaard; Thomas Benfield
Journal:  Crit Care       Date:  2009       Impact factor: 9.097

10.  Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.

Authors:  Chun Geun Lee; Dominik Hartl; Gap Ryol Lee; Barbara Koller; Hiroshi Matsuura; Carla A Da Silva; Myung Hyun Sohn; Lauren Cohn; Robert J Homer; Alexander A Kozhich; Alison Humbles; Jennifer Kearley; Anthony Coyle; Geoffrey Chupp; Jennifer Reed; Richard A Flavell; Jack A Elias
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.